L01XX Other antineoplastic agents
ATC group of level 4 – chemical subgroup · in plain English: cancer medicines
This site has the patient leaflet or the SPC of 59 medicines in this group and its subgroups.
- 36 prescription only (POM)
- 6 no longer supplied or not available
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01X Other antineoplastic agents 225 medicines
-
L01XX Other antineoplastic agents 59 medicines
- L01XX01 amsacrine 1 medicine
- L01XX02 asparaginase 3 medicines
- L01XX05 hydroxycarbamide 9 medicines
- L01XX08 pentostatin 1 medicine
- L01XX23 mitotane 3 medicines
- L01XX24 pegaspargase 3 medicines
- L01XX27 arsenic trioxide 7 medicines
- L01XX33 celecoxib 1 medicine
- L01XX35 anagrelide 13 medicines
- L01XX41 eribulin 6 medicines
- L01XX44 aflibercept 1 medicine
- L01XX51 talimogene laherparepvec 3 medicines
- L01XX52 venetoclax 3 medicines
- L01XX66 selinexor 1 medicine
- L01XX67 tagraxofusp 1 medicine
- L01XX69 lurbinectedin 1 medicine
- L01XX71 tisagenlecleucel 1 medicine
-
L01XX Other antineoplastic agents 59 medicines
- L01X Other antineoplastic agents 225 medicines
- L01 Antineoplastic agents 1,025 medicines
16 more subgroups have no medicine with a leaflet on this site.
Active substances in the group
- Aflibercept 1 medicine
- Amsacrine 1 medicine
- Anagrelide 13 medicines
- Arsenic 6 medicines
- Arsenic trioxide 1 medicine
- Asparaginase 1 medicine
- Celecoxib 1 medicine
- Crisantaspase 2 medicines
- Eribulin 6 medicines
- Hydroxycarbamide 9 medicines
- Mitotane 3 medicines
- Pegaspargase 3 medicines
- Pentostatin 1 medicine
- Rucaparib 1 medicine
- Selinexor 1 medicine
- Tagraxofusp 1 medicine
- Talimogene laherparepvec 3 medicines
- Tisagenlecleucel 1 medicine
- Venetoclax 3 medicines
Medicines in the group and its subgroups
Other groups of the same level
- L01XA Platinum compounds, antineoplastic drugs 11 medicines
- L01XB Methylhydrazines, antineoplastics 1 medicine
- L01XC Monoclonal antibodies, antineoplastic 73 medicines
- L01XD Sensitizers used in photodynamic/radiation therapy 10 medicines
- L01XF Retinoids for cancer treatment 2 medicines
- L01XG Proteasome inhibitors, antineoplastic agent 43 medicines
- L01XH Histone deacetylase (HDAC) inhibitors 3 medicines
- L01XJ Hedgehog pathway inhibitors 4 medicines
- L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors 13 medicines
- L01XY Combinations of antineoplastic agents 4 medicines
Other names of the ATC group
- Czech: L01XX Jiná cytostatika
- French: L01XX autres antinéoplasiques
- German: L01XX Andere antineoplastische Mittel
- Spanish: L01XX Otros antineoplasicos
- German: L01XX Andere antineoplastische Mittel
- Italian: L01XX ALTRI ANTINEOPLASTICI
- Polish: L01XX Inne cytostatyki
- Turkish: L01XX ATC'deki diğer antineoplastik ajanlar
- Portuguese (Brazil): L01XX Outros agentes anti-neoplásicos
- Slovak: L01XX Iné cytostatiká
- German (Switzerland): L01XX Andere antineoplastische Mittel
- French (Switzerland): L01XX Autres antinéoplasiques
- Italian (Switzerland): L01XX Altri antineoplastici
- Dutch: L01XX Overige oncolytica
- English (Canada): L01XX Other antineoplastic agents
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01XX
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
